Regular article
Presentation of cervical cancer

https://doi.org/10.1016/0090-8258(91)90229-XGet rights and content

Abstract

To determine how patients with invasive cervical cancer present and whether presentation affects disease-free survival (DFS), a review of 81 patients treated for cervical cancer by the Division of Gynecologic Oncology and Pelvic Surgery at the Southern California Permanente Medical Group between January 1, 1986, and December 31, 1986, was performed. Fifty-six percent of patients presented with abnormal vaginal bleeding, twenty-eight percent presented with abnormal Papanicolaou (Pap) smears, nine percent presented with pain, four percent presented with vaginal discharge, and four percent presented with other symptoms. Follow-up was 24 to 41 months. Patients presenting with abnormal Pap smears had DFS of 96%. Those presenting with abnormal vaginal bleeding had DFS of 51% and those presenting with pain had DFS of 29%. Presentation strongly influences DFS (χ2 = 16.8, P < 0.001). Of women presenting with abnormal Pap smears, 87% were Stage I and 13% were Stage II. Of women presenting with other than abnormal Pap smears, 40% were Stage I, 34% were Stage II, and 26% were Stage III or IV. Presentation with abnormal Pap smear and stage are significantly related (χ2 = 14.8, P < 0.001). Of women presenting with abnormal Pap smears, 89% had cancers 0 to 2 cm, 5% had cancers 2.1 to 4 cm, and 5% had cancers greater than 4 cm in diameter. Of women presenting with other than abnormal Pap smears, 21% had cancers 0 to 2 cm, 26% had cancers 2.1 to 4 cm, and 53% had cancers greater than 4 cm in diameter. Presentation with abnormal Pap smear is significantly associated with tumor size (χ2 = 25.4, P < 0.001). Logistic regression analysis was performed utilizing stage, tumor size, and presentation as independent variables with disease-free survival as the dependent variable. Once stage and tumor size had been controlled for, presentation with abnormal Pap smear no longer predicted disease-free survival (P > 0.1). Abnormal Pap smears are a common presentation of invasive cervical cancer. Presentation with abnormal Pap smear is associated with early stage and small tumor size but is not an independent predictor of disease-free survival.

References (16)

There are more references available in the full text version of this article.

Cited by (69)

  • British Gynaecological Cancer Society (BGCS) cervical cancer guidelines: Recommendations for practice

    2021, European Journal of Obstetrics and Gynecology and Reproductive Biology
    Citation Excerpt :

    It is possible for women of all ages to develop cervical cancer, but traditionally the condition mainly affected sexually active women aged between 30 and 45 years of age, however, recent data from Cancer Research UK shows the peak age of incidence has reduced to 25–29 years of age. Cervical cancer is very rare in women under 25 years old [4] and may be more difficult to prevent in younger age women. ( https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/cervical-cancer#heading-Zero).

  • Chapter 13 - Cervical Squamous Neoplasia

    2017, Diagnostic Gynecologic and Obstetric Pathology
  • Abnormal vaginal bleeding in women with gynaecological malignancies

    2017, Best Practice and Research: Clinical Obstetrics and Gynaecology
    Citation Excerpt :

    Macroscopic cervical tumour usually presents with postcoital or irregular bleeding and an offensive vaginal discharge. The adenocarcinoma histological subtype may be less likely to present with postcoital bleeding as lesions may be high in the endocervix and protected from the trauma of sexual intercourse [29]. Women with locally advanced disease may complain of pain and the cancer may erode into the bladder or rectum causing fistulas.

  • Uncommon Vaginitis Cases: Expect the Unexpected

    2015, Journal for Nurse Practitioners
  • Cervix

    2009, Modern Surgical Pathology
  • Cervix

    2009, Modern Surgical Pathology
View all citing articles on Scopus

The conclusions stated in this manuscript are those of the authors. They do not represent statements or conclusions of the Southern California Permanente Medical Group.

View full text